GS TFC (Mekinist 0.5 mg)
Generic Name: trametinib
Pill with imprint GS TFC is Yellow, Elliptical/Oval and has been identified as Mekinist 0.5 mg. It is supplied by GlaxoSmithKline.
Mekinist is used in the treatment of melanoma, metastatic; non-small cell lung cancer; thyroid cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Mekinist 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GS TFC
Mekinist
- Generic Name
- trametinib
- Imprint
- GS TFC
- Strength
- 0.5 mg
- Color
- Yellow
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
hypromelloses,
croscarmellose sodium,
magnesium stearate,
sodium lauryl sulfate,
silicon dioxide,
titanium dioxide,
polyethylene glycol,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00173-0849 (Discontinued) | GlaxoSmithKline |
| 00078-0666 | Novartis Pharmaceuticals Corporation |
More about Mekinist (trametinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.